December 4, 2020 NVAC Meeting (Virtual)

December 4, 2020

Agenda

Draft NVAC Agenda: December 4, 2020

Time Agenda Item
1:00 pm – 1:10 pm

CALL TO ORDER AND RULES OF ENGAGEMENT
Ann Aikin, Acting Designated Federal Official

1:10 pm – 1:20 pm OPENING REMARKS
Admiral Brett Giroir, Assistant Secretary for Health
1:20 pm – 1:30 pm CHAIR’S WELCOME
Dr. Robert Hopkins, NVAC Chair
1:30 pm – 2:00 pm PERSPECTIVE: WHY CHILDREN SHOULD EVENTUALLY RECEIVE VACCINES AGAINST SARS-2 CORONAVIRUS
Dr. Stanley Plotkin, University of Pennsylvania (Emeritus)
2:00 pm – 2:45 pm

APPROACHES TO INCLUDE PREGNANT WOMEN IN COVID-19 CLINICAL TRIALS

  • Dr. Sascha Ellington, Centers for Disease Control and Prevention
  • Dr. Ruth Faden, Johns Hopkins University
  • Dr. Jeff Roberts, U.S. Food and Drug Administration
  • Dr. Linda Eckert, University of Washington and Representing American College of Obstetricians and Gynecologists
  • Dr. Dana Meaney-Delman, Centers for Disease Control and Prevention
  • Dr. Titi Oduyebo, Centers for Disease Control and Prevention
2:45 pm – 3:00 pm BREAK
3:00 pm – 4:00 pm

VACCINE SAFETY SYSTEMS AND COVID-19

  • Dr. Peter Marks, U.S. Food and Drug Administration
  • Dr. Arnold Monto, University of Michigan and Representing the Vaccines and Related Biological Products Advisory Committee
  • Dr. Tom Shimabukuro, Centers for Disease Control and Prevention
  • Dr. Sonali Kochhar, University of Washington
4:00 pm – 4:15 pm

NO COPAYS: COVERAGE FOR COVID-19 VACCINES
Jeff Wu, Centers for Medicare & Medicaid Services
4:15 pm – 4:30 pm

REPORT OVERVIEW
Dr. Robert Hopkins, NVAC Chair
4:30 pm – 4:45 pm PUBLIC COMMENT
4:45 pm – 5:30 pm

COMMITTEE DISCUSSION AND VOTE
Dr. Robert Hopkins, NVAC Chair

This meeting was held virtually.

View the Meeting Minutes*

Federal Register Notice

View Videos

View the Meeting Recording - Part 1 (Opening, the perspective presentation by Stanley Plotkin, and the panel on pregnant women)

View the Meeting Recording - Part 2 (The vaccine safety systems panel, the presentation on coverage for COVID-19 vaccines, and the report, overview, discussion and vote)

*People using assistive technology may not be able to fully access information in these files. For assistance, contact the HHS Office of Infectious Disease and HIV/AIDS Policy by emailing Ann.Aikin@hhs.gov.

Content created by Office of Infectious Disease and HIV/AIDS Policy (OIDP)
Content last reviewed